NASDAQ:NXGN - Nextgen Healthcare Stock Price, News & Analysis

$14.76
-0.05 (-0.34 %)
(As of 08/21/2019 08:29 AM ET)
Today's Range
$14.55
Now: $14.76
$15.03
50-Day Range
$14.27
MA: $17.66
$20.32
52-Week Range
$13.60
Now: $14.76
$23.17
Volume157,759 shs
Average Volume483,306 shs
Market Capitalization$965.01 million
P/E Ratio24.20
Dividend YieldN/A
Beta1.01
NextGen Healthcare, Inc. provides software, services, and analytics solutions to medical and dental group practices in the United States. The company's principal products include NextGen Enterprise EHR, which stores and maintains clinical patient information; and a workflow module, prescription management, automatic document and letter generation, patient education, referral tracking, interfaces to billing and lab systems, physician alerts and reminders, and reporting and data analysis tools. Its products also comprise NextGen Enterprise PM, a practice management (PM) solution; and NextGen Office, a cloud-based electronic health record and PM solution. In addition, the company offers automation and workflow solutions, including NextGen Mobile Health Solutions, NextGen Electronic Healthcare Transactions, NextGen Pre-Service Clearance, and NextGen Patient Payment solutions. Further, it provides analytics, population health, and patient engagement solutions, such as NextGen Population Health Informed Analytics, NextGen Population Health Patient Care Coordination, NextGen Population Health Performance Management, and NextGen Patient Portal solutions. Additionally, the company offers NextGen Connected Health and NextGen Share interoperability solutions. It also provides professional services, including training, project management, functional and detailed specification preparation, configuration, testing, installation, support, and client services. It serves physician hospital and management service organizations, independent physician associations, accountable care organizations, ambulatory care centers, and community health centers through a sales force and reseller channel. NextGen Healthcare, Inc. has a strategic partnership with OTTO Health LLC. The company was formerly known as Quality Systems, Inc. and changed its name to NextGen Healthcare, Inc. in September 2018. NextGen Healthcare, Inc. was founded in 1974 and is headquartered in Irvine, California.

Industry, Sector and Symbol

Industry Computer integrated systems design
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:NXGN
CUSIPN/A
CIKN/A
Phone949-255-2600

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$529.17 million
Cash Flow$1.2880 per share
Book Value$5.81 per share

Profitability

Net Income$24.49 million

Miscellaneous

Employees2,660
Market Cap$965.01 million
Next Earnings Date10/29/2019 (Estimated)
OptionableOptionable

Receive NXGN News and Ratings via Email

Sign-up to receive the latest news and ratings for NXGN and its competitors with MarketBeat's FREE daily newsletter.


Nextgen Healthcare (NASDAQ:NXGN) Frequently Asked Questions

What is Nextgen Healthcare's stock symbol?

Nextgen Healthcare trades on the NASDAQ under the ticker symbol "NXGN."

How were Nextgen Healthcare's earnings last quarter?

Nextgen Healthcare Inc (NASDAQ:NXGN) announced its quarterly earnings results on Wednesday, July, 24th. The company reported $0.10 EPS for the quarter, missing the consensus estimate of $0.15 by $0.05. The company had revenue of $131.86 million for the quarter, compared to analyst estimates of $136.33 million. Nextgen Healthcare had a net margin of 4.37% and a return on equity of 10.05%. The company's revenue for the quarter was down 1.0% on a year-over-year basis. During the same quarter last year, the business earned $0.19 EPS. View Nextgen Healthcare's Earnings History.

When is Nextgen Healthcare's next earnings date?

Nextgen Healthcare is scheduled to release their next quarterly earnings announcement on Tuesday, October 29th 2019. View Earnings Estimates for Nextgen Healthcare.

What guidance has Nextgen Healthcare issued on next quarter's earnings?

Nextgen Healthcare updated its FY20 earnings guidance on Wednesday, July, 24th. The company provided earnings per share (EPS) guidance of $0.82-0.90 for the period, compared to the Thomson Reuters consensus estimate of $0.90. The company issued revenue guidance of $536-550 million, compared to the consensus revenue estimate of $550.83 million.

What price target have analysts set for NXGN?

6 brokers have issued twelve-month price targets for Nextgen Healthcare's shares. Their predictions range from $16.00 to $23.00. On average, they anticipate Nextgen Healthcare's stock price to reach $19.20 in the next twelve months. This suggests a possible upside of 30.1% from the stock's current price. View Analyst Price Targets for Nextgen Healthcare.

What is the consensus analysts' recommendation for Nextgen Healthcare?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nextgen Healthcare in the last year. There are currently 2 sell ratings, 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Nextgen Healthcare.

What are Wall Street analysts saying about Nextgen Healthcare stock?

Here are some recent quotes from research analysts about Nextgen Healthcare stock:
  • 1. According to Zacks Investment Research, "NextGen exited the fiscal first quarter on a dull note, with earnings and revenues missing the consensus mark. However, the company witnessed significant deal-size growth in the quarter under review. Solid bookings growth in the quarter deserves a mention as well. Impressive rates of client addition have worked well for NextGen. Expansion in operating margin is an added positive. On the flip side, the company’s Recurring and Software, Hardware and Other non-recurring revenues were soft in the quarter under review. The company’s top line also fell on a year-over-year basis. Significant contraction in gross margin raises concern. Slashed guidance for fiscal 2020 raises concern as well. Additionally, NextGen faces stiff rivalry in the MedTech space. The stock has underperformed the industry over the past year." (7/30/2019)
  • 2. Cantor Fitzgerald analysts commented, ". We reiterate our Overweight rating on NXGN shares and maintain our price target of $23. We recently met with NXGN management team. We remain confident that some of the issues that came up with its F2Q19 results (reported in late October) were temporary in nature. As a reminder, F2Q19 bookings were about $36 million, representing growth of 39% y/y, which is impressive. However, as deal size increases, implementation timelines expand and short-term revenue is not hitting expectations. The company also experienced higher-than-expected customer attrition. After considering the elevated attrition during the quarter and the company’s expectation that it will remain elevated for some time, we reduced our F20 revenue growth assumption to 5.7% from 7.0%." (12/6/2018)

Has Nextgen Healthcare been receiving favorable news coverage?

News coverage about NXGN stock has been trending positive this week, according to InfoTrie Sentiment Analysis. InfoTrie rates the sentiment of news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Nextgen Healthcare earned a media sentiment score of 2.5 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 6.0 out of 10, meaning that recent news coverage is somewhat likely to have an impact on the stock's share price in the immediate future. View News Stories for Nextgen Healthcare.

Are investors shorting Nextgen Healthcare?

Nextgen Healthcare saw a increase in short interest in July. As of July 31st, there was short interest totalling 2,178,500 shares, an increase of 6.5% from the June 30th total of 2,045,900 shares. Based on an average daily trading volume, of 345,100 shares, the short-interest ratio is presently 6.3 days. Currently, 4.6% of the company's shares are sold short. View Nextgen Healthcare's Current Options Chain.

Who are some of Nextgen Healthcare's key competitors?

What other stocks do shareholders of Nextgen Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nextgen Healthcare investors own include Celgene (CELG), GW Pharmaceuticals PLC- (GWPH), Twitter (TWTR), Verizon Communications (VZ), Intel (INTC), NVIDIA (NVDA), Best Buy (BBY), Bristol-Myers Squibb (BMY), Bank of Hawaii (BOH) and Caterpillar (CAT).

Who are Nextgen Healthcare's key executives?

Nextgen Healthcare's management team includes the folowing people:
  • Mr. John R. Frantz, Pres, CEO & Director (Age 52)
  • Mr. James Robert Arnold Jr., Exec. VP, CFO & Principal Accounting Officer (Age 63)
  • Mr. David A. Metcalfe, Exec. VP & Chief Technology Officer (Age 56)
  • Mr. Jeffrey D. Linton, Exec. VP, Gen. Counsel & Sec. (Age 56)
  • Mr. Scott E. Bostick, Non-Exec. Officer (Age 54)

Who are Nextgen Healthcare's major shareholders?

Nextgen Healthcare's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Brown Capital Management LLC (13.92%), BlackRock Inc. (11.75%), Vanguard Group Inc. (8.51%), Investment Counselors of Maryland LLC (2.05%), Northern Trust Corp (1.08%) and Paradigm Capital Management Inc. NY (0.93%). Company insiders that own Nextgen Healthcare stock include George H Bristol and Sheldon Razin. View Institutional Ownership Trends for Nextgen Healthcare.

Which major investors are selling Nextgen Healthcare stock?

NXGN stock was sold by a variety of institutional investors in the last quarter, including Invesco Ltd., Bank of New York Mellon Corp, Jacobs Levy Equity Management Inc., Brown Capital Management LLC, D. E. Shaw & Co. Inc., Citadel Advisors LLC, AXA and AQR Capital Management LLC. Company insiders that have sold Nextgen Healthcare company stock in the last year include George H Bristol and Sheldon Razin. View Insider Buying and Selling for Nextgen Healthcare.

Which major investors are buying Nextgen Healthcare stock?

NXGN stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Nuveen Asset Management LLC, Marshall Wace LLP, Prudential Financial Inc., Vanguard Group Inc., Allianz Asset Management GmbH, State Board of Administration of Florida Retirement System and Acadian Asset Management LLC. View Insider Buying and Selling for Nextgen Healthcare.

How do I buy shares of Nextgen Healthcare?

Shares of NXGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Nextgen Healthcare's stock price today?

One share of NXGN stock can currently be purchased for approximately $14.76.

How big of a company is Nextgen Healthcare?

Nextgen Healthcare has a market capitalization of $965.01 million and generates $529.17 million in revenue each year. The company earns $24.49 million in net income (profit) each year or $0.61 on an earnings per share basis. Nextgen Healthcare employs 2,660 workers across the globe.View Additional Information About Nextgen Healthcare.

What is Nextgen Healthcare's official website?

The official website for Nextgen Healthcare is http://www.nextgen.com/.

How can I contact Nextgen Healthcare?

Nextgen Healthcare's mailing address is 18111 Von Karman Avenue Suite 800, Irvine CA, 92612. The company can be reached via phone at 949-255-2600 or via email at [email protected]


MarketBeat Community Rating for Nextgen Healthcare (NASDAQ NXGN)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  69 (Vote Outperform)
Underperform Votes:  87 (Vote Underperform)
Total Votes:  156
MarketBeat's community ratings are surveys of what our community members think about Nextgen Healthcare and other stocks. Vote "Outperform" if you believe NXGN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NXGN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/21/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel